Tasman Pharma Drug Patent Portfolio
Tasman Pharma owns 1 orange book drug protected by 1 US patent Given below is the list of Tasman Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8057811 | Stable clozapine suspension formulation | 01 May, 2028 | Active |
Latest Legal Activities on Tasman Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Tasman Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 10 May, 2023 | US8057811 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Feb, 2019 | US8057811 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 05 May, 2015 | US8057811 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Nov, 2011 | US8057811 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Nov, 2011 | US8057811 |
|
Email Notification
Critical
| 28 Oct, 2011 | US8057811 |
|
Issue Notification Mailed
Critical
| 26 Oct, 2011 | US8057811 |
| Dispatch to FDC | 14 Oct, 2011 | US8057811 |
|
Application Is Considered Ready for Issue
Critical
| 11 Oct, 2011 | US8057811 |
|
Issue Fee Payment Verified
Critical
| 23 Sep, 2011 | US8057811 |
|
Issue Fee Payment Received
Critical
| 23 Sep, 2011 | US8057811 |
|
Mail Notice of Allowance
Critical
| 16 Sep, 2011 | US8057811 |
|
Electronic Review
Critical
| 16 Sep, 2011 | US8057811 |
|
Email Notification
Critical
| 16 Sep, 2011 | US8057811 |
|
Notice of Allowance Data Verification Completed
Critical
| 13 Sep, 2011 | US8057811 |
Tasman Pharma's Family Patents
Tasman Pharma drugs have patent protection in a total of 6 countries. It's US patent count contributes only to 25.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Tasman Pharma Drug List
Given below is the complete list of Tasman Pharma's drugs and the patents protecting them.
1. Versacloz
Versacloz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8057811 | Stable clozapine suspension formulation |
01 May, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Versacloz's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List